CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Jul. 03, 2015		Jun. 27, 2014
Cash flows from operating activities:
Net earnings	$ 312,925		$ 297,838
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense	36,594		30,054
Tax benefits from exercises of share-based payment awards	12,300		9,882
Excess tax benefits from share-based compensation	(12,303)		(9,850)
Depreciation	44,893		42,717
Amortization of intangible assets	5,112		3,259
Impairment of a privately-held equity investment	0		7,725
Deferred taxes	15,218		(4,689)
Provision for doubtful accounts receivable	2,811		5,662
Other, net	1,386		(1,750)
Changes in assets and liabilities, net of effects of acquisition:
Accounts receivable	14,045		(67,947)
Inventories	(77,288)		(49,060)
Prepaid expenses and other assets	(32,702)		(22,147)
Accounts payable	281		(14,020)
Accrued expenses and other liabilities	(39,845)		(14,768)
Deferred revenues and advance payments from customers	32,740		42,683
Net cash provided by operating activities	316,167		255,589
Cash flows from investing activities:
Purchases of property, plant and equipment	(57,084)		(63,229)
Investment in available-for-sale corporate debt securities	(942)		(40,692)
Sale of a portion of investment in available-for-sale corporate debt security	0		38,075
Acquisitions of businesses, net of cash acquired	(11,585)		(15,500)
Notes receivable	(5,000)		(5,500)
Net amounts received from deferred compensation plan trust account	2,507		0
Other, net	(1,085)		642
Net cash used in investing activities	(73,189)		(86,204)
Cash flows from financing activities:
Repurchases of common stock	(293,570)		(417,245)
Proceeds from issuance of common stock to employees	86,536		84,107
Excess tax benefits from share-based compensation	12,303		9,850
Employees' taxes withheld and paid for restricted stock and restricted stock units	(16,200)		(8,664)
Borrowings received under credit facility agreement	125,000		0
Repayments under credit facility agreement and other bank borrowings	(162,500)		(56,250)
Net borrowings received under credit facility agreements with maturities less than 90 days	95,478		29,553
Capital contribution from noncontrolling interest holders	2,893		0
Other	(3,341)		(616)
Net cash used in financing activities	(153,401)		(359,265)
Effects of exchange rate changes on cash and cash equivalents	12,585		(1,994)
Net increase/(decrease) in cash and cash equivalents	102,162		(191,874)
Cash and cash equivalents at beginning of period	849,275	[1]	1,117,861
Cash and cash equivalents at end of period	$ 951,437		$ 925,987

[1] The condensed consolidated balance sheet as of September 26, 2014 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.